vs

Side-by-side financial comparison of SURF AIR MOBILITY INC. (SRFM) and X4 Pharmaceuticals, Inc (XFOR). Click either name above to swap in a different company.

X4 Pharmaceuticals, Inc is the larger business by last-quarter revenue ($28.8M vs $26.4M, roughly 1.1× SURF AIR MOBILITY INC.). X4 Pharmaceuticals, Inc runs the higher net margin — 1.0% vs -139.4%, a 140.4% gap on every dollar of revenue.

Surf Air Mobility Inc. is an American aviation company focused on regional flying. The company plans to develop electric and hybrid powertrains to upgrade existing aircraft. Surf Air Mobility is also developing AI-enabled SurfOS operating system for the regional air mobility industry. Surf Air Mobility is the parent company of Surf Air, Surf On Demand, and two airlines, Mokulele Airlines and Southern Airways Express.

X4 Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel targeted therapies for rare immunological diseases and oncology indications with high unmet medical needs. It operates primarily across the U.S. and European markets, with a lead pipeline candidate for WHIM syndrome and multiple other preclinical and clinical assets for immune disorders and cancer.

SRFM vs XFOR — Head-to-Head

Bigger by revenue
XFOR
XFOR
1.1× larger
XFOR
$28.8M
$26.4M
SRFM
Higher net margin
XFOR
XFOR
140.4% more per $
XFOR
1.0%
-139.4%
SRFM

Income Statement — Q4 FY2025 vs Q1 FY2025

Metric
SRFM
SRFM
XFOR
XFOR
Revenue
$26.4M
$28.8M
Net Profit
$-36.9M
$282.0K
Gross Margin
83.6%
Operating Margin
-97.8%
-32.8%
Net Margin
-139.4%
1.0%
Revenue YoY
-5.7%
Net Profit YoY
-3015.3%
100.5%
EPS (diluted)
$-0.08
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SRFM
SRFM
XFOR
XFOR
Q4 25
$26.4M
Q3 25
$29.2M
Q2 25
$27.4M
Q1 25
$23.5M
$28.8M
Q4 24
$28.0M
Q3 24
$28.4M
Q2 24
$32.4M
Q1 24
$30.6M
$0
Net Profit
SRFM
SRFM
XFOR
XFOR
Q4 25
$-36.9M
Q3 25
$-27.2M
Q2 25
$-28.0M
Q1 25
$-18.5M
$282.0K
Q4 24
$1.3M
Q3 24
$-12.2M
Q2 24
$-27.0M
Q1 24
$-37.0M
$-51.8M
Gross Margin
SRFM
SRFM
XFOR
XFOR
Q4 25
Q3 25
Q2 25
Q1 25
83.6%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
SRFM
SRFM
XFOR
XFOR
Q4 25
-97.8%
Q3 25
-56.6%
Q2 25
-58.1%
Q1 25
-79.0%
-32.8%
Q4 24
28.9%
Q3 24
-30.4%
Q2 24
-78.0%
Q1 24
-112.6%
Net Margin
SRFM
SRFM
XFOR
XFOR
Q4 25
-139.4%
Q3 25
-93.3%
Q2 25
-102.1%
Q1 25
-78.6%
1.0%
Q4 24
4.5%
Q3 24
-43.1%
Q2 24
-83.4%
Q1 24
-120.7%
EPS (diluted)
SRFM
SRFM
XFOR
XFOR
Q4 25
$-0.08
Q3 25
$-0.64
Q2 25
$-1.34
Q1 25
$-1.09
$0.04
Q4 24
$0.80
Q3 24
$-0.94
Q2 24
$-2.31
Q1 24
$-3.35
$-7.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SRFM
SRFM
XFOR
XFOR
Cash + ST InvestmentsLiquidity on hand
$12.7M
$40.3M
Total DebtLower is stronger
$17.1M
$75.0M
Stockholders' EquityBook value
$-54.9M
$22.9M
Total Assets
$131.7M
$130.0M
Debt / EquityLower = less leverage
3.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SRFM
SRFM
XFOR
XFOR
Q4 25
$12.7M
Q3 25
$7.1M
Q2 25
$22.6M
Q1 25
$6.6M
$40.3M
Q4 24
$21.1M
Q3 24
$506.0K
Q2 24
$1.5M
Q1 24
$1.3M
$60.5M
Total Debt
SRFM
SRFM
XFOR
XFOR
Q4 25
$17.1M
Q3 25
$63.8M
Q2 25
$63.3M
Q1 25
$62.9M
$75.0M
Q4 24
$62.4M
Q3 24
$22.5M
Q2 24
$23.3M
Q1 24
$25.1M
$55.0M
Stockholders' Equity
SRFM
SRFM
XFOR
XFOR
Q4 25
$-54.9M
Q3 25
$-92.6M
Q2 25
$-115.5M
Q1 25
$-135.6M
$22.9M
Q4 24
$-120.0M
Q3 24
$-135.6M
Q2 24
$-128.1M
Q1 24
$-106.3M
$1.0M
Total Assets
SRFM
SRFM
XFOR
XFOR
Q4 25
$131.7M
Q3 25
$106.8M
Q2 25
$129.0M
Q1 25
$105.3M
$130.0M
Q4 24
$124.1M
Q3 24
$97.9M
Q2 24
$105.5M
Q1 24
$108.8M
$112.2M
Debt / Equity
SRFM
SRFM
XFOR
XFOR
Q4 25
Q3 25
Q2 25
Q1 25
3.27×
Q4 24
Q3 24
Q2 24
Q1 24
53.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SRFM
SRFM
XFOR
XFOR
Operating Cash FlowLast quarter
$-18.4M
$-12.4M
Free Cash FlowOCF − Capex
$-20.1M
FCF MarginFCF / Revenue
-76.0%
Capex IntensityCapex / Revenue
6.5%
0.0%
Cash ConversionOCF / Net Profit
-43.86×
TTM Free Cash FlowTrailing 4 quarters
$-70.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SRFM
SRFM
XFOR
XFOR
Q4 25
$-18.4M
Q3 25
$-19.3M
Q2 25
$-10.6M
Q1 25
$-15.8M
$-12.4M
Q4 24
$-23.6M
Q3 24
$-12.3M
Q2 24
$-5.6M
Q1 24
$-12.8M
$-33.6M
Free Cash Flow
SRFM
SRFM
XFOR
XFOR
Q4 25
$-20.1M
Q3 25
$-21.1M
Q2 25
$-11.9M
Q1 25
$-17.1M
Q4 24
$-32.7M
Q3 24
$-13.6M
Q2 24
$-6.3M
Q1 24
$-13.5M
$-33.7M
FCF Margin
SRFM
SRFM
XFOR
XFOR
Q4 25
-76.0%
Q3 25
-72.2%
Q2 25
-43.2%
Q1 25
-72.6%
Q4 24
-116.5%
Q3 24
-47.8%
Q2 24
-19.5%
Q1 24
-44.2%
Capex Intensity
SRFM
SRFM
XFOR
XFOR
Q4 25
6.5%
Q3 25
5.9%
Q2 25
4.4%
Q1 25
5.4%
0.0%
Q4 24
32.4%
Q3 24
4.4%
Q2 24
2.2%
Q1 24
2.3%
Cash Conversion
SRFM
SRFM
XFOR
XFOR
Q4 25
Q3 25
Q2 25
Q1 25
-43.86×
Q4 24
-18.64×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SRFM
SRFM

Scheduled$17.2M65%
On Demand$9.2M35%

XFOR
XFOR

Segment breakdown not available.

Related Comparisons